Organovo Holdings, Inc. announced that its board of directors has appointed one new member. David Shapiro, M.D., Chief Medical Officer of Intercept Pharmaceuticals, Inc., will join Board as Class I Director, effective December 4, 2018. Dr. Shapiro's appointment increases the number of Organovo directors to eight. Dr. David Shapiro has over 30 years of clinical development experience in the pharmaceutical industry. He has served as the Chief Medical Officer of Intercept Pharmaceuticals, Inc. since November 2017, having previously served as its Chief Medical Officer and Executive Vice President, Development since 2008.